8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 20, 2024 · 2y ago · Accession 0001140361-24-030718
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ROCKET PHARMACEUTICALS, INC.
- Ticker
- RCKTW
- CIK
- 1281895
- Form type
- 8-K
- Filing date
- Jun 20, 2024
- Report date
- Jun 13, 2024
- Document
- ef20031374_8k.htm
- Size
- 199 KB